• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于基因集活性的风险评分模型作为子宫内膜异位症诊断生物标志物的识别与验证

Identification and validation of risk score model based on gene set activity as a diagnostic biomarker for endometriosis.

作者信息

Zhang Yi, Wu Lulu, Wen Xiang, Lv Xiuwei

机构信息

Department of Gynecology, Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410005, China.

Department of Integrated Traditional Chinese and Western Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China.

出版信息

Heliyon. 2023 Jul 15;9(7):e18277. doi: 10.1016/j.heliyon.2023.e18277. eCollection 2023 Jul.

DOI:10.1016/j.heliyon.2023.e18277
PMID:37539146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10395533/
Abstract

OBJECTIVE

The enigmatic nature of Endometriosis (EMS) pathogenesis necessitates investigating alterations in signaling pathway activity to enhance our comprehension of the disease's characteristics.

METHODS

Three published gene expression profiles (GSE11691, GSE25628, and GSE7305 datasets) were downloaded, and the "combat" algorithm was employed for batch correction, gene expression difference analysis, and pathway enrichment difference analysis. The protein-protein interaction (PPI) network was constructed to identify core genes, and the relative enrichment degree of gene sets was evaluated. The Lasso regression model identified candidate gene sets with diagnostic value, and a risk scoring diagnostic model was constructed for further validation on the GSE86534 and GSE5108 datasets. CIBERSORT was used to assess the composition of immune cells in EMS, and the correlation between EMS diagnostic value gene sets and immune cells was evaluated.

RESULTS

A total of 568 differentially expressed genes were identified between eutopic and ectopic endometrium, with 10 core genes in the PPI network associated with cell cycle regulation. Inflammation-related pathways, including cytokine-receptor signaling and chemokine signaling pathways, were significantly more active in ectopic endometrium compared to eutopic endometrium. Diagnostic gene sets for EMS, such as homologous recombination, base excision repair, DNA replication, P53 signaling pathway, adherens junction, and SNARE interactions in vesicular transport, were identified. The risk score's area under the curve (AUC) was 0.854, as indicated by the receiver operating characteristic (ROC) curve, and the risk score's diagnostic value was validated by the validation cohort. Immune cell infiltration analysis revealed correlations between the risk score and Macrophages M2, Plasma cells, resting NK cells, activated NK cells, and regulatory T cells.

CONCLUSION

The risk scoring diagnostic model, based on pathway activity, demonstrates high diagnostic value and offers novel insights and strategies for the clinical diagnosis and treatment of Endometriosis.

摘要

目的

子宫内膜异位症(EMS)发病机制的神秘本质使得有必要研究信号通路活性的改变,以加深我们对该疾病特征的理解。

方法

下载了三个已发表的基因表达谱(GSE11691、GSE25628和GSE7305数据集),并采用“combat”算法进行批次校正、基因表达差异分析和通路富集差异分析。构建蛋白质-蛋白质相互作用(PPI)网络以识别核心基因,并评估基因集的相对富集程度。Lasso回归模型识别具有诊断价值的候选基因集,并构建风险评分诊断模型,在GSE86534和GSE5108数据集上进行进一步验证。使用CIBERSORT评估EMS中免疫细胞的组成,并评估EMS诊断价值基因集与免疫细胞之间的相关性。

结果

在位内膜和异位内膜之间共鉴定出568个差异表达基因,PPI网络中有10个核心基因与细胞周期调控相关。与炎症相关的通路,包括细胞因子-受体信号通路和趋化因子信号通路,在异位内膜中比在位内膜中显著更活跃。鉴定出了EMS的诊断基因集,如同源重组、碱基切除修复、DNA复制、P53信号通路、黏着连接以及囊泡运输中的SNARE相互作用。接受者操作特征(ROC)曲线显示,风险评分的曲线下面积(AUC)为0.854,验证队列验证了风险评分的诊断价值。免疫细胞浸润分析揭示了风险评分与M2巨噬细胞、浆细胞、静息自然杀伤细胞、活化自然杀伤细胞和调节性T细胞之间的相关性。

结论

基于通路活性的风险评分诊断模型具有较高的诊断价值,为子宫内膜异位症的临床诊断和治疗提供了新的见解和策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/9082f690538c/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/cbb448ad78ed/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/262f7c39a7ec/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/0a56f3864100/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/485b1a0c680a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/6efc342f933b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/f11cd9a32216/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/9082f690538c/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/cbb448ad78ed/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/262f7c39a7ec/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/0a56f3864100/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/485b1a0c680a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/6efc342f933b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/f11cd9a32216/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0bd/10395533/9082f690538c/gr7.jpg

相似文献

1
Identification and validation of risk score model based on gene set activity as a diagnostic biomarker for endometriosis.基于基因集活性的风险评分模型作为子宫内膜异位症诊断生物标志物的识别与验证
Heliyon. 2023 Jul 15;9(7):e18277. doi: 10.1016/j.heliyon.2023.e18277. eCollection 2023 Jul.
2
Diagnostic gene biomarkers for predicting immune infiltration in endometriosis.用于预测子宫内膜异位症免疫浸润的诊断基因生物标志物。
BMC Womens Health. 2022 May 18;22(1):184. doi: 10.1186/s12905-022-01765-3.
3
Bioinformatical analysis identifies PDLIM3 as a potential biomarker associated with immune infiltration in patients with endometriosis.生物信息学分析鉴定 PDLIM3 为子宫内膜异位症患者免疫浸润相关的潜在生物标志物。
PeerJ. 2022 Mar 30;10:e13218. doi: 10.7717/peerj.13218. eCollection 2022.
4
Bioinformatics identification and validation of biomarkers and infiltrating immune cells in endometriosis.生物信息学鉴定和验证子宫内膜异位症的生物标志物和浸润免疫细胞。
Front Immunol. 2022 Nov 29;13:944683. doi: 10.3389/fimmu.2022.944683. eCollection 2022.
5
Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation.基于生物信息学分析、机器学习和实验验证揭示与铁死亡相关的子宫内膜异位症的发病机制、生物标志物和潜在治疗药物。
J Biol Eng. 2024 Jul 26;18(1):42. doi: 10.1186/s13036-024-00437-0.
6
Analysis of characteristic genes and ceRNA regulation mechanism of endometriosis based on full transcriptional sequencing.基于全转录组测序的子宫内膜异位症特征基因及ceRNA调控机制分析
Front Genet. 2022 Jul 22;13:902329. doi: 10.3389/fgene.2022.902329. eCollection 2022.
7
Identification and Validation of the Signatures of Infiltrating Immune Cells in the Eutopic Endometrium Endometria of Women With Endometriosis.识别和验证子宫内膜异位症患者在位子宫内膜中浸润免疫细胞的特征。
Front Immunol. 2021 Sep 3;12:671201. doi: 10.3389/fimmu.2021.671201. eCollection 2021.
8
Common and specific gene signatures among three different endometriosis subtypes.三种不同子宫内膜异位症亚型中的常见和特异性基因特征。
PeerJ. 2020 Mar 5;8:e8730. doi: 10.7717/peerj.8730. eCollection 2020.
9
Identification of immune- and autophagy-related genes and effective diagnostic biomarkers in endometriosis: a bioinformatics analysis.子宫内膜异位症中免疫和自噬相关基因的鉴定及有效诊断生物标志物:一项生物信息学分析
Ann Transl Med. 2022 Dec;10(24):1397. doi: 10.21037/atm-22-5979.
10
Signatures of necroptosis-related genes as diagnostic markers of endometriosis and their correlation with immune infiltration.坏死性凋亡相关基因特征作为子宫内膜异位症的诊断标志物及其与免疫浸润的相关性。
BMC Womens Health. 2023 Oct 11;23(1):535. doi: 10.1186/s12905-023-02668-7.

本文引用的文献

1
FAVOR: functional annotation of variants online resource and annotator for variation across the human genome.FAVOR:在线变体功能注释资源和人类基因组变异注释器。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1300-D1311. doi: 10.1093/nar/gkac966.
2
Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer.染色体框蛋白4(CBX4)通过激活细胞分裂周期蛋白20(CDC20)促进胃癌的肿瘤进展和干性。
J Gastrointest Oncol. 2022 Jun;13(3):1058-1072. doi: 10.21037/jgo-22-549.
3
Diagnostic gene biomarkers for predicting immune infiltration in endometriosis.
用于预测子宫内膜异位症免疫浸润的诊断基因生物标志物。
BMC Womens Health. 2022 May 18;22(1):184. doi: 10.1186/s12905-022-01765-3.
4
Transcription factor HOXB2 upregulates NUSAP1 to promote the proliferation, invasion and migration of nephroblastoma cells via the PI3K/Akt signaling pathway.转录因子 HOXB2 通过 PI3K/Akt 信号通路上调 NUSAP1 促进肾母细胞瘤细胞的增殖、侵袭和迁移。
Mol Med Rep. 2022 Jun;25(6). doi: 10.3892/mmr.2022.12721. Epub 2022 Apr 29.
5
Upregulation of Cyclin B2 () in breast cancer contributes to the development of lymphovascular invasion.乳腺癌中细胞周期蛋白B2()的上调促进淋巴管浸润的发生。
Am J Cancer Res. 2022 Feb 15;12(2):469-489. eCollection 2022.
6
Overexpression of abnormal spindle-like microcephaly-associated (ASPM) increases tumor aggressiveness and predicts poor outcome in patients with lung adenocarcinoma.异常纺锤样小头畸形相关蛋白(ASPM)的过表达会增加肺腺癌患者的肿瘤侵袭性并预示不良预后。
Transl Cancer Res. 2021 Feb;10(2):983-997. doi: 10.21037/tcr-20-2570.
7
The deep infiltrating endometriosis tissue has lower T-cadherin, E-cadherin, progesterone receptor and oestrogen receptor than endometrioma tissue.深部浸润型子宫内膜异位症组织中的 T 钙黏蛋白、E 钙黏蛋白、孕激素受体和雌激素受体的表达水平低于卵巢子宫内膜异位囊肿组织。
Taiwan J Obstet Gynecol. 2021 Nov;60(6):1059-1065. doi: 10.1016/j.tjog.2021.09.017.
8
Long-term trends in the incidence of endometriosis in China from 1990 to 2019: a joinpoint and age-period-cohort analysis.1990年至2019年中国子宫内膜异位症发病率的长期趋势:连接点和年龄-时期-队列分析
Gynecol Endocrinol. 2021 Nov;37(11):1041-1045. doi: 10.1080/09513590.2021.1975675. Epub 2021 Sep 14.
9
PPARγ Agonists: Emergent Therapy in Endometriosis.过氧化物酶体增殖物激活受体γ激动剂:子宫内膜异位症的新兴治疗方法
Pharmaceuticals (Basel). 2021 Jun 6;14(6):543. doi: 10.3390/ph14060543.
10
Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing.单细胞RNA测序揭示子宫内膜异位症腹腔液中的细胞亚型和免疫功能障碍
Cell Biosci. 2021 May 26;11(1):98. doi: 10.1186/s13578-021-00613-5.